Brian Ball, Stephen Strickland, Briggs Morrison, John DiPersio, Shaliny Kushwaha, Benjamin Lee, Rachel Ghiraldi, Kevin Cho, John Goll, David Sallman, Ghayas Issa. "A first-in-human phase 1 Study of cbx-250, a TCR-mimetic bispecific T cell engager targeting CG1/ HLA-a*02:01 in patients with relapsed or refractory AML, HR-MDS, or CMML (CROSSCHECK-001) (Trial in Progress)." Blood, 2025. doi:10.1182/blood-2025-3430